Literature DB >> 28842527

Mechanisms contributing to cardiac remodelling.

Qing-Qing Wu1,2,3, Yang Xiao1,2,3, Yuan Yuan1,2,3, Zhen-Guo Ma1,2,3, Hai-Han Liao1,2,3, Chen Liu1,2,3, Jin-Xiu Zhu1,2,3, Zheng Yang1,2,3, Wei Deng1,2,3, Qi-Zhu Tang4,2,3.   

Abstract

Cardiac remodelling is classified as physiological (in response to growth, exercise and pregnancy) or pathological (in response to inflammation, ischaemia, ischaemia/reperfusion (I/R) injury, biomechanical stress, excess neurohormonal activation and excess afterload). Physiological remodelling of the heart is characterized by a fine-tuned and orchestrated process of beneficial adaptations. Pathological cardiac remodelling is the process of structural and functional changes in the left ventricle (LV) in response to internal or external cardiovascular damage or influence by pathogenic risk factors, and is a precursor of clinical heart failure (HF). Pathological remodelling is associated with fibrosis, inflammation and cellular dysfunction (e.g. abnormal cardiomyocyte/non-cardiomyocyte interactions, oxidative stress, endoplasmic reticulum (ER) stress, autophagy alterations, impairment of metabolism and signalling pathways), leading to HF. This review describes the key molecular and cellular responses involved in pathological cardiac remodelling.
© 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  cardiac remodelling; cardiomyocytes; heart failure; noncardiomyocytes; signalling

Mesh:

Year:  2017        PMID: 28842527     DOI: 10.1042/CS20171167

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  43 in total

1.  NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression.

Authors:  Fangfang Li; Hao Zhang; Lu Yang; Hui Yong; Qingqing Qin; Mengtong Tan; Luhong Xu; Kai Liang; Jing Zong; Wenhao Qian
Journal:  J Mol Med (Berl)       Date:  2018-08-29       Impact factor: 4.599

Review 2.  Insights into circular RNAs: their biogenesis, detection, and emerging role in cardiovascular disease.

Authors:  Zoe Ward; John Pearson; Sebastian Schmeier; Vicky Cameron; Anna Pilbrow
Journal:  RNA Biol       Date:  2021-03-28       Impact factor: 4.652

Review 3.  Cardiac Remodelling Following Cancer Therapy: A Review.

Authors:  Tan Panpan; Du Yuchen; Shi Xianyong; Liu Meng; He Ruijuan; Dong Ranran; Zhang Pengyan; Li Mingxi; Xie Rongrong
Journal:  Cardiovasc Toxicol       Date:  2022-07-25       Impact factor: 2.755

4.  Tax1 banding protein 1 exacerbates heart failure in mice by activating ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis.

Authors:  Qing-Qing Wu; Qi Yao; Tong-Tong Hu; Ying Wan; Qing-Wen Xie; Jin-Hua Zhao; Yuan Yuan; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2022-08-10       Impact factor: 7.169

5.  Cardiomyocyte peroxisome proliferator-activated receptor α is essential for energy metabolism and extracellular matrix homeostasis during pressure overload-induced cardiac remodeling.

Authors:  Xia Wang; Xin-Xin Zhu; Shi-Yu Jiao; Dan Qi; Bao-Qi Yu; Guo-Min Xie; Ye Liu; Yan-Ting Song; Qing Xu; Qing-Bo Xu; Frank J Gonzalez; Jie Du; Xiao-Min Wang; Ai-Juan Qu
Journal:  Acta Pharmacol Sin       Date:  2021-08-10       Impact factor: 7.169

6.  Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

Authors:  Xin Zhang; Can Hu; Hai-Ming Wu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

Review 7.  Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases.

Authors:  Ahmed S Bayoumi; Tatsuya Aonuma; Jian-Peng Teoh; Yao-Liang Tang; Il-Man Kim
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

8.  Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy.

Authors:  Lu Zhang; Jiaqi He; Junyan Wang; Jing Liu; Zixin Chen; Bo Deng; Lan Wei; Hanqin Wu; Birong Liang; Huan Li; Yusheng Huang; Lu Lu; Zhongqi Yang; Shaoxiang Xian; Lingjun Wang
Journal:  Cell Death Dis       Date:  2021-05-11       Impact factor: 8.469

9.  6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway.

Authors:  Shu-Qing Ma; Zhen Guo; Fang-Yuan Liu; Shahzad-Gul Hasan; Dan Yang; Nan Tang; Peng An; Ming-Yu Wang; Hai-Ming Wu; Zheng Yang; Di Fan; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2021-01-18       Impact factor: 7.169

10.  Cardiac Chamber Quantification by Echocardiography in Adults With Sickle Cell Disease: Need Attention to Eccentric Hypertrophy.

Authors:  Mahmut B Koyuncu; Anil Tombak; Ozcan Orscelik; Tolga Koseci; Ali Turker; Hakan Basir; Aydan Akdeniz; Eyup N Tiftik
Journal:  Cureus       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.